Your session is about to expire
← Back to Search
Cue-Reward Intervention with possible intensification for Rheumatic Diseases
N/A
Waitlist Available
Led By Candace H Feldman, MD, ScD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 weeks
Awards & highlights
Study Summary
This trial will test whether the "repetition-cue-reward" model of healthy habit formation can help patients with arthritis and other rheumatic diseases to be more consistent in taking their medication as prescribed.
Eligible Conditions
- Rheumatic Diseases
- Systemic Lupus Erythematosus
- Gout
- Medication Adherence
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rate of Medication Adherence
Secondary outcome measures
Change in Uric Acid Level From Baseline
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Cue-Reward Intervention with possible intensification.Experimental Treatment1 Intervention
Patients in this intervention arm will choose an event-based cue. Additionally, a donation will be made to a local charity every time they take their medication. Those who show no improvement in adherence after 6 weeks will start receiving reminder text messages reminding them of their cue.
Group II: Cue-Reward InterventionExperimental Treatment1 Intervention
Patients in this intervention arm will choose an event-based cue and receive reminder text messages reminding them of their cue. Additionally, a donation will be made to a local charity every time they take their medication.
Group III: ControlActive Control1 Intervention
Patients in the control arm will not receive any intervention (but will receive electronic pill bottles to monitor their adherence).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cue-Reward Intervention with possible intensification
2021
N/A
~70
Cue-Reward Intervention
2021
N/A
~70
Find a Location
Who is running the clinical trial?
Brigham and Women's HospitalLead Sponsor
1,605 Previous Clinical Trials
11,467,234 Total Patients Enrolled
4 Trials studying Rheumatic Diseases
3,060 Patients Enrolled for Rheumatic Diseases
National Institute on Aging (NIA)NIH
1,665 Previous Clinical Trials
28,005,017 Total Patients Enrolled
Candace H Feldman, MD, ScDPrincipal InvestigatorBrigham and Women's Hospital
2 Previous Clinical Trials
325 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this research include participants younger than 70 years of age?
"This clinical trial seeks participants who are aged 18 to 85 years old."
Answered by AI
Are there any eligibility requirements for participation in this clinical trial?
"Admittance to this trial is dependent on the patient having a rheumatic illness and being between 18-85 years old. 70 people will be accepted in total."
Answered by AI
Are new participants being invited to join this clinical experiment?
"The study detailed on clinicaltrials.gov is not presently accepting applications, as the last edit was made in October 2022. However, there are 272 other studies that still require participants to join their trials."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger